Cambridge Molecular is a biotechnology company specializing in the development of advanced molecular modeling and simulation technologies. The company focuses on leveraging artificial intelligence and machine learning to enhance drug discovery processes, optimize molecular designs, and improve the efficiency of pharmaceutical research. Through its innovative approach, Cambridge Molecular aims to accelerate the development of new therapeutics and provide solutions for complex biological challenges.